PR1-Specific Cytotoxic T-Lymphocyte Infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PR1-Specific Cytotoxic T-Lymphocyte Infusion, covering 2014-03-04 to 2014-03-04. Get the full timeline:
Most recent: Clinical Trial Update: PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation [Phase 1]